MedTrace Logo

Norepinephrine in Caesarian Section

NCT05264870 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-09-10

No results posted yet for this study

Summary

Postspinal hypotension is a frequent maternal complication in caesarian delivery under neuraxial anesthesia which is most commonly treated with the administration of phenylephrine infusion. In this trial, postspinal hypotension will be treated with norepinephrine. The main objective is to examine the pharmacodynamic and biochemical effect of norepinephrine both on mother and newborn.

Conditions

  • Cesarean Section Complications
  • Hemodynamic Instability
  • Foetal Stress

Interventions

DRUG

Norepinephrine

treatment of postspinal hypotension

DRUG

Norepinephrine

treatment of postspinal hypotension

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Hanne Ryckebosch, MD · University Hospital, Antwerp

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-09
Primary Completion
2023-03-02
Completion
2025-08-27

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05264870 on ClinicalTrials.gov